TCG Crossover Management, LLC - KURA ONCOLOGY INC ownership

KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 142 filers reported holding KURA ONCOLOGY INC in Q4 2022. The put-call ratio across all filers is 0.82 and the average weighting 0.3%.

Quarter-by-quarter ownership
TCG Crossover Management, LLC ownership history of KURA ONCOLOGY INC
ValueSharesWeighting
Q3 2023$12,983,615
-13.8%
1,423,6420.0%1.91%
-22.6%
Q2 2023$15,062,132
-13.5%
1,423,6420.0%2.47%
-27.2%
Q1 2023$17,411,142
-1.5%
1,423,6420.0%3.39%
+8.9%
Q4 2022$17,667,397
-4.1%
1,423,642
+5.6%
3.12%
-43.6%
Q3 2022$18,422,000
-13.9%
1,348,642
+15.5%
5.52%
-39.2%
Q2 2022$21,403,000
+162.8%
1,167,642
+130.6%
9.09%
+178.1%
Q1 2022$8,143,000506,4233.27%
Other shareholders
KURA ONCOLOGY INC shareholders Q4 2022
NameSharesValueWeighting ↓
ARCH Venture Management, LLC 206,307$3,363,00011.31%
Foresite Capital Management IV, LLC 1,307,982$21,320,00010.39%
EcoR1 Capital, LLC 4,608,529$75,119,0005.55%
Prosight Management, LP 685,000$11,166,0004.79%
ACUTA CAPITAL PARTNERS, LLC 872,500$14,222,0004.11%
BVF INC/IL 2,775,882$45,247,0002.79%
VR Adviser, LLC 575,000$9,373,0002.24%
ALETHEA CAPITAL MANAGEMENT, LLC 216,171$3,524,0002.06%
DAFNA Capital Management LLC 294,260$4,796,0001.38%
Vivo Capital, LLC 1,050,000$17,115,0001.23%
View complete list of KURA ONCOLOGY INC shareholders